Horizon Therapeutics Public Limited Company, often referred to simply as Horizon Therapeutics, is a biopharmaceutical firm headquartered in Ireland (IE). Founded in 2008, the company has rapidly established itself within the global pharmaceutical industry, focusing on the development and commercialisation of innovative medicines for rare and rheumatic diseases. Horizon Therapeutics is renowned for its core products, including Tepezza and Krystexxa, which address significant unmet medical needs. These therapies are distinguished by their unique mechanisms of action and commitment to improving patient outcomes. With a strong market position, Horizon has achieved notable milestones, including strategic acquisitions that have expanded its portfolio and global reach, particularly in North America and Europe.
We don't have data for Horizon Therapeutics Public Limited Company, but we can show you information about their parent organization instead.
View parent company